Prior Treatment Failure: Addressing the Challenge in HIV CarePremiere Date: Monday, August 30, 2021
This activity offers CE credit for:%>
- ABIM (MOC)
- Medicine (accme)
- Nursing (ANCC)
- Pharmacy (acpe)
- PA (aapa)
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Tuesday, August 30, 2022
Note: Credit Is No Longer Available
|Eric S. Daar, MD
Chief, Division of HIV Medicine
Harbor-UCLA Medical Center
Investigator, Lundquist Institute
Professor of Medicine
David Geffen School of Medicine at UCLA
Los Angeles, CA
When there has been prior treatment failure in a patient with HIV, clinicians need to identify any patient-related, HIV-related, and ART regimen-related factors that may be contributing to virologic failure and drug resistance, and apply guideline-recommended algorithms to clinical decisions for managing ART failure.
The final installment in this CME Outfitters BriefCase series on addressing real-world clinical challenges in optimizing care of HIV includes a case study on Luke, a 41-year-old man, (MSM), diagnosed with HIV 20 years ago, that will show learners how to effectively translate new knowledge of current and emerging treatments into their clinical practice.
At the end of this CE activity, participants should be able to:
- Integrate best practices for initiating and switching patients to ART based on safety and efficacy profiles.
- Translate emerging data from national conferences to treatment decisions in clinical practice.
Supported by an educational grant from Gilead Sciences, Inc.
Physicians, PAs, nurse practitioners, and pharmacists
ABIM MOC Credit:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to .5 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Learning formats: Enduring material
Royal College MOC:Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.
This activity counts towards MIPS Improvement Activity requirements under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Daar reports that he receives research support from Gilead Sciences, Inc. and ViiV Healthcare. He is a consultant for Gilead Sciences, Inc.; Merck & Co., Inc.; and ViiV Healthcare.
Maria Glukhovsky, PharmD (planning committee) has no disclosures to report.
Jan Perez (planning committee) has no disclosures to report.
Sharon Tordoff (planning committee) has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).